Manufacturer record

Kerala State Drugs Pharmaceuticals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Kerala State Drugs Pharmaceuticals Ltd (Kerala) were declared Not of Standard Quality between October 2024 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Kerala State Drugs Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Oct 2024 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2024
4
Products affected
Other
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2024 · 22026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Diclofenac Sodium Tablets IP 50 mg DG 5033Mfg 2025-03 · Exp 2027-02 The sample does not conform to IP standards with respect to the test Dissolution and also shows Category B defect of tablets (Capping).Dissolution DTL, ThrissurState lab Jul 2026
Diclofenac Sodium Tabelts IP 50 mg DG5034Mfg 2025-03 · Exp 2027-02 The sample does not conform to IP standards. If fails the Descriptive part as per IP,as specified in the Laboratory Protocol.Other DTL TVPMState lab Jun 2026
Chlorpromazine Tablets IP 50 mg S73010Mfg 2023-03 · Exp 2025-02 The sample fails in the ?Descriptive Part? for Tablets as per IPOther DTL ThiruvananthapuramState lab Nov 2024
Theophylline & Etophylline Tablets TE4029Mfg 2024-04 · Exp 2027-03 It fails the test ?Disintegration? Specified in the Laboratory Protocol as per IPDisintegration DTL ThiruvananthapuramState lab Oct 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.